Literature DB >> 28924425

Blood Group Distribution in Switzerland - a Historical Comparison.

Thomas Volken1, Rebecca J Crawford1,2, Soraya Amar3, Edgar Mosimann4, Anita Tschaggelar3, Behrouz Mansouri Taleghani5.   

Abstract

BACKGROUND: Ethnicities differ in prevalence of blood groups and antigens. Substantial donor-recipient mismatch within mixed-ethnic societies may render certain recipients at higher risk for alloimmunization. Data regarding antigen distribution within Switzerland by ethnicity is limited. We examined immigration patterns against the distribution of ABO blood groups using large cross-sectional Swiss samples spanning 70 years.
METHODS: Historical ABO blood group distribution data (1940-1945) from Swiss army personnel (n = 275,664) were sourced from the literature. Recent blood group phenotypes of 122,925 individuals who presented themselves at army recruitment centers (2004-2015) were obtained, alongside a validation sample of 175,202 patients from a university hospital. Two-sample tests with z-statistics assessing blood groups between samples were used.
RESULTS: The respective proportions of A (47.2% and 45.2%), B (8.4% and 9.8%), and AB (3.0 and 4.1) in the historical and recent army samples were significantly different (p < 0.001), while group O was not.
Conclusion: ABO blood groups in Switzerland have remained stable despite substantial immigration with a changing foreign-national profile. Further research is needed to improve the understanding of antigen differences in newly introduced ethnic groups. Blood product requirements and public health initiatives aimed at recruiting blood donors would benefit from this information.

Entities:  

Keywords:  Blood group; Ethnic minority; Rare blood types; Switzerland

Year:  2017        PMID: 28924425      PMCID: PMC5597946          DOI: 10.1159/000479191

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  32 in total

1.  Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

Authors:  France Noizat-Pirenne; Ketty Lee; Pierre-Yves Le Pennec; Philippe Simon; Philippe Kazup; Dora Bachir; Anne-Marie Rouzaud; Michele Roussel; Geneviève Juszczak; Cècile Ménanteau; Philippe Rouger; Rami Kotb; Jean-Pierre Cartron; Hélène Ansart-Pirenne
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

2.  Contribution of attitudinal factors to blood donation in African American church attendees.

Authors:  Adelbert B James; Derrick G Demmons; George B Schreiber; Christopher D Hillyer; Beth H Shaz
Journal:  Transfusion       Date:  2010-09-14       Impact factor: 3.157

3.  ABO, Rh, MNS, Duffy, Kidd,Yt, Scianna, and Colton blood group systems in indigenous Chinese.

Authors:  L Yan; F Zhu; Q Fu; J He
Journal:  Immunohematology       Date:  2005

4.  The immediate and long-term benefits of a broad-based rare donor program.

Authors:  K M Beattie; S L Cisco; M M Winkler; A W Shafer
Journal:  Immunohematology       Date:  1986

5.  Red blood cell antigen genotype analysis for 9087 Asian, Asian American, and Native American blood donors.

Authors:  Meghan Delaney; Samantha Harris; Askale Haile; Jill Johnsen; Gayle Teramura; Karen Nelson
Journal:  Transfusion       Date:  2015-05-28       Impact factor: 3.157

6.  ABO genotyping by TaqMan assay and allele frequencies in a Japanese population.

Authors:  Kazuho Maeda; Shigeki Nakamura; Chikako Murakami; Wataru Irie; Toshimasa Watanabe; Chizuko Sasaki; Naomi Nakamaru; Masataka Furukawa; Katsuyoshi Kurihara
Journal:  Leg Med (Tokyo)       Date:  2012-10-12       Impact factor: 1.376

7.  Blood donors in England and North Wales: demography and patterns of donation.

Authors:  Samuel Lattimore; Crispin Wickenden; Susan R Brailsford
Journal:  Transfusion       Date:  2014-09-01       Impact factor: 3.157

8.  Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.

Authors:  Oswaldo Castro; S Gerald Sandler; Patricia Houston-Yu; Sohail Rana
Journal:  Transfusion       Date:  2002-06       Impact factor: 3.157

9.  Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.

Authors:  Matthew S Karafin; Joshua J Field; Jerome L Gottschall; Gregory A Denomme
Journal:  Transfusion       Date:  2015-03-09       Impact factor: 3.157

10.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Authors:  Stella T Chou; Tannoa Jackson; Sunitha Vege; Kim Smith-Whitley; David F Friedman; Connie M Westhoff
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113

View more
  5 in total

1.  [The patient blood group-the small but important difference].

Authors:  R Zimmermann; H Hackstein
Journal:  Anaesthesist       Date:  2018-09       Impact factor: 1.041

2.  Phenotype, Allele and Genotype Frequency of ABO and Rhesus D Blood Groups of Blood Donors at the North Gondar District Blood Bank, Northwest Ethiopia.

Authors:  Berhanu Woldu; Mulugeta Melku; Elias Shiferaw; Belete Biadgo; Molla Abebe; Yemataw Gelaw
Journal:  J Blood Med       Date:  2022-01-06

3.  Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation.

Authors:  Baptiste Lemaire; Christophe Combescure; Yves Chalandon; Nicolas Vuilleumier; Sophie Waldvogel Abramowski
Journal:  Bone Marrow Transplant       Date:  2022-06-25       Impact factor: 5.174

4.  The genomic landscape of blood groups in Indigenous Australians in remote communities.

Authors:  Sudhir Jadhao; Wendy Hoy; Simon Lee; Hardip R Patel; Brendan J McMorran; Robert L Flower; Shivashankar H Nagaraj
Journal:  Transfusion       Date:  2022-04-11       Impact factor: 3.337

Review 5.  Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection.

Authors:  Saeed M Kabrah; Ahmed M Kabrah; Arwa F Flemban; Samer Abuzerr
Journal:  Transfus Apher Sci       Date:  2021-05-21       Impact factor: 1.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.